FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+19.03%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$21B
AUM Growth
+$356M
(+1.7%)
Cap. Flow
-$1.66B
Cap. Flow
% of AUM
-7.93%
Top 10 Holdings %
Top 10 Hldgs %
50.08%
Holding
490
New
56
Increased
117
Reduced
220
Closed
84
Top Buys
| 1 |
Tesla
TSLA
|
$183M |
| 2 |
United Airlines
UAL
|
$156M |
| 3 |
Global E Online
GLBE
|
$155M |
| 4 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
$155M |
| 5 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$116M |
Top Sells
| 1 |
TSMC
TSM
|
$359M |
| 2 |
Applovin
APP
|
$327M |
| 3 |
Astera Labs
ALAB
|
$191M |
| 4 |
Natera
NTRA
|
$157M |
| 5 |
Danaher
DHR
|
$114M |
Sector Composition
| 1 | Technology | 37.03% |
| 2 | Communication Services | 15.92% |
| 3 | Consumer Discretionary | 13.84% |
| 4 | Industrials | 12.34% |
| 5 | Healthcare | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Vertex Pharmaceuticals
VRTX
$102B
| $2.12M | 0.01% |
5,262
-12,773
| -71% | -$5.14M |
|
327
NewAmsterdam Pharma
NAMS
$3.04B
| $2.07M | 0.01% |
+80,579
| New | +$2.07M |
|
328
Rapid7
RPD
$1.32B
| $2.03M | 0.01% |
50,424
-27
| -0.1% | -$1.09K |
|
329
MYR Group
MYRG
$2.79B
| $2M | 0.01% |
13,464
-3,047
| -18% | -$453K |
|
330
Grocery Outlet
GO
$1.8B
| $1.99M | 0.01% |
127,625
-82
| -0.1% | -$1.28K |
|
331
Merus
MRUS
$5.1B
| $1.99M | 0.01% |
47,288
-10,658
| -18% | -$448K |
|
|
GAP
332
The Gap, Inc.
GAP
$8.83B
| $1.97M | 0.01% |
+83,338
| New | +$1.97M |
|
333
CorVel
CRVL
$4.39B
| $1.93M | 0.01% |
+17,390
| New | +$1.93M |
|
334
Marqeta
MQ
$2.76B
| $1.91M | 0.01% |
503,533
+709
| +0.1% | +$2.69K |
|
335
Denali Therapeutics
DNLI
$2.26B
| $1.87M | 0.01% |
91,807
-29,509
| -24% | -$601K |
|
336
Structure Therapeutics
GPCR
$1.27B
| $1.81M | 0.01% |
66,662
-51
| -0.1% | -$1.38K |
|
337
RadNet
RDNT
$5.49B
| $1.78M | 0.01% |
+25,503
| New | +$1.78M |
|
338
Oric Pharmaceuticals
ORIC
$1.06B
| $1.77M | 0.01% |
219,276
-171
| -0.1% | -$1.38K |
|
339
Salesforce
CRM
$239B
| $1.76M | 0.01% |
5,270
-379
| -7% | -$127K |
|
340
McKesson
MCK
$85.5B
| $1.76M | 0.01% |
3,091
+1,510
| +96% | +$861K |
|
341
Trimble
TRMB
$19.2B
| $1.75M | 0.01% |
24,717
+18,796
| +317% | +$1.33M |
|
342
BioMarin Pharmaceuticals
BMRN
$11.1B
| $1.7M | 0.01% |
25,870
-703
| -3% | -$46.2K |
|
343
Scholar Rock
SRRK
$3.02B
| $1.65M | 0.01% |
+38,172
| New | +$1.65M |
|
344
MaxCyte
MXCT
$150M
| $1.62M | 0.01% |
389,435
-183
| -0% | -$761 |
|
345
PepsiCo
PEP
$200B
| $1.61M | 0.01% |
10,512
-39,919
| -79% | -$6.12M |
|
346
HealthEquity
HQY
$7.88B
| $1.58M | 0.01% |
+16,497
| New | +$1.58M |
|
|
CBLL
347
CeriBell, Inc. Common Stock
CBLL
$433M
| $1.57M | 0.01% |
+60,761
| New | +$1.57M |
|
|
BCPC
348
Balchem Corporation
BCPC
$5.23B
| $1.52M | 0.01% |
9,267
| – | – |
|
349
GSK
GSK
$81.5B
| $1.52M | 0.01% |
44,303
-498
| -1% | -$17K |
|
350
Encompass Health
EHC
$12.6B
| $1.46M | 0.01% |
15,837
-14,804
| -48% | -$1.37M |
|